McGuire Andrew, Brown James A L, Malone Carmel, McLaughlin Ray, Kerin Michael J
Discipline of Surgery, School of Medicine, National University of Ireland, Galway, Ireland.
Cancers (Basel). 2015 May 22;7(2):908-29. doi: 10.3390/cancers7020815.
Currently, breast cancer affects approximately 12% of women worldwide. While the incidence of breast cancer rises with age, a younger age at diagnosis is linked to increased mortality. We discuss age related factors affecting breast cancer diagnosis, management and treatment, exploring key concepts and identifying critical areas requiring further research. We examine age as a factor in breast cancer diagnosis and treatment relating it to factors such as genetic status, breast cancer subtype, hormone factors and nodal status. We examine the effects of age as seen through the adoption of population wide breast cancer screening programs. Assessing the incidence rates of each breast cancer subtype, in the context of age, we examine the observed correlations. We explore how age affects patient's prognosis, exploring the effects of age on stage and subtype incidence. Finally we discuss the future of breast cancer diagnosis and treatment, examining the potential of emerging tests and technologies (such as microRNA) and how novel research findings are being translated into clinically relevant practices.
目前,乳腺癌影响着全球约12%的女性。虽然乳腺癌的发病率随年龄增长而上升,但诊断时年龄较小与死亡率增加有关。我们讨论影响乳腺癌诊断、管理和治疗的年龄相关因素,探讨关键概念并确定需要进一步研究的关键领域。我们将年龄作为乳腺癌诊断和治疗中的一个因素,将其与基因状态、乳腺癌亚型、激素因素和淋巴结状态等因素联系起来。我们通过采用全人群乳腺癌筛查项目来研究年龄的影响。在年龄背景下评估每种乳腺癌亚型的发病率,我们研究观察到的相关性。我们探讨年龄如何影响患者的预后,研究年龄对分期和亚型发病率的影响。最后,我们讨论乳腺癌诊断和治疗的未来,研究新兴检测和技术(如微小RNA)的潜力,以及新的研究发现如何转化为临床相关实践。